Explore expert-vetted resources on diseases of mind and sight.
Blood tests for Alzheimer’s disease are emerging as a promising tool for early detection, potentially identifying the disease before symptoms appear. Learn how these tests work and what they could mean for future diagnosis and treatment options.
Learn some helpful behavioral and environmental tips to manage sundowning, which can occur in older persons, with or without dementia, during late afternoon and evening.
In this timely discussion, Dr. Suzanne Schindler will explain how blood-based biomarkers are transforming Alzheimer’s diagnosis, research, and care.
Dr. Karl Wahlin explores how regenerative medicine and retinal cell replacement strategies could transform the future of glaucoma treatment and vision preservation.
Dr. Gil Rabinovici explores trontinemab, an investigational next-generation anti-amyloid therapy being studied for early Alzheimer’s disease.
Dr. April McCullough of Regeneron and Katherine Freund of Independent Transportation Network of America discuss the real-world barriers that prevent people with vision loss from accessing timely eye care and solutions that are available.
